Plasma GDF15 levels associated with circulating immune cells predict the efficacy of PD-1/PD-L1 inhibitor treatment and prognosis in patients with advanced non-small cell lung cancer

被引：0
|
作者：
Green Hong
Pureum Sun
Chaeuk Chung
Dongil Park
Song-I Lee
Nayoung Kim
Seong Eun Lee
Jeong Eun Lee
Yea Eun Kang
Da Hyun Kang
机构：
[1] Chungnam National University,Department of Internal Medicine, College of Medicine
[2] Chungnam National University,Institute for Medical Sciences, College of Medicine
来源：
Journal of Cancer Research and Clinical Oncology | 2023年 / 149卷
关键词：
GDF15; Non-small cell lung cancer; Immunotherapy; Survival; Biomarker; Efficacy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：159 / 171
页数：12
相关论文
共 50 条
  • [41] The progress and confusion of anti-PD1/PD-L1 immunotherapy for patients with advanced non-small cell lung cancer
    Zhang, Shuling
    Bai, Xueli
    Shan, Fengping
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2020, 80
  • [42] PD-L1 polymorphisms predict survival outcomes in advanced non-small-cell lung cancer patients treated with PD-1 blockade
    Yoshida, Hironori
    Nomizo, Takashi
    Ozasa, Hiroaki
    Tsuji, Takahiro
    Funazo, Tomoko
    Yasuda, Yuto
    Ajimizu, Hitomi
    Yamazoe, Masatoshi
    Kuninaga, Kiyomitsu
    Ogimoto, Tatsuya
    Hosoya, Kazutaka
    Itotani, Ryo
    Sakamori, Yuichi
    Kim, Young Hak
    Hirai, Toyohiro
    EUROPEAN JOURNAL OF CANCER, 2021, 144 : 317 - 325
  • [43] Tumor response assessment by measuring the single largest lesion per organ in advanced non-small cell lung cancer patients treated with PD-1/PD-L1 inhibitor
    He, Li-Na
    Chen, Tao
    Fu, Sha
    Jiang, Yongluo
    Zhang, Xuanye
    Chen, Chen
    Du, Wei
    Luo, Linfeng
    Li, Anlin
    Wang, Yixing
    Yu, Hui
    Zhou, Yixin
    Wang, Yuhong
    Yang, Yunpeng
    Huang, Yan
    Zhao, Hongyun
    Fang, Wenfeng
    Zhang, Li
    Hong, Shaodong
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2023, 15
  • [44] Peripheral inflammatory factors as prognostic predictors for first-line PD-1/PD-L1 inhibitors in advanced non-small cell lung cancer
    Jin, Chen-xing
    Liu, Yan-song
    Qin, He-nan
    Teng, Yi-bin
    Sun, Rui
    Ma, Zhong-jing
    Wang, A-man
    Liu, Ji-wei
    SCIENTIFIC REPORTS, 2025, 15 (01):
  • [45] High SHP2 expression determines the efficacy of PD-1/PD-L1 inhibitors in advanced KRAS mutant non-small cell lung cancer
    Feng, Hui-Bo
    Chen, Yu
    Xie, Zhi
    Jiang, Jie
    Zhong, Yu-Min
    Guo, Wei-Bang
    Yan, Wen-Qing
    Lv, Zhi-Yi
    Lu, Dan-Xia
    Liang, Hong-Ling
    Xu, Fang-Ping
    Yang, Jin-Ji
    Yang, Xue-Ning
    Zhou, Qing
    Zhang, Dong-Kun
    Zhang, Zhou
    Chuai, Shao-Kun
    Zhang, Heng-Hui
    Wu, Yi-Long
    Zhang, Xu-Chao
    THORACIC CANCER, 2021, 12 (19) : 2564 - 2573
  • [46] Targeting the PD-1/PD-L1 axis for the treatment of non-small-cell lung cancer
    Meyers, D. E.
    Bryan, P. M.
    Banerji, S.
    Morris, D. G.
    CURRENT ONCOLOGY, 2018, 25 (04) : E324 - E334
  • [47] Novel Immunotherapeutics for the Treatment of Non-Small Cell Lung Cancer (NSCLC) Resistant to PD-1/PD-L1 Inhibitors
    Malhotra, Jyoti
    Huang, Amy
    Amini, Arya
    Lee, Percy
    CANCERS, 2024, 16 (21)
  • [48] Expression of PD-1/PD-L1 and PD-L2 in peripheral T-cells from non-small cell lung cancer patients
    Arrieta, Oscar
    Montes-Servin, Edgar
    Hernandez-Martinez, Juan-Manuel
    Cardona, Andres F.
    Casas-Ruiz, Eibar
    Crispin, Jose C.
    Motola, Daniel
    Flores-Estrada, Diana
    Barrera, Lourdes
    ONCOTARGET, 2017, 8 (60) : 101994 - 102005
  • [49] Investigation of PD-L1 Biomarker Testing Methods for PD-1 Axis Inhibition in Non-squamous Non-small Cell Lung Cancer
    Sheffield, Brandon S.
    Fulton, Regan
    Kalloger, Steve E.
    Milne, Katy
    Geller, Georgia
    Jones, Martin
    Jacquemont, Celine
    Zachara, Susanna
    Zhao, Eric
    Pleasance, Erin
    Laskin, Janessa
    Jones, Steven J. M.
    Marra, Marco A.
    Yip, Stephen
    Nelson, Brad H.
    Gown, Allen M.
    Ho, Cheryl
    Ionescu, Diana N.
    JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 2016, 64 (10) : 587 - 600
  • [50] Circulating regulatory T cells predict efficacy and atypical responses in lung cancer patients treated with PD-1/PD-L1 inhibitors
    Da Hyun Kang
    Chaeuk Chung
    Pureum Sun
    Da Hye Lee
    Song-I Lee
    Dongil Park
    Jeong Suk Koh
    Yoonjoo Kim
    Hyon-Seung Yi
    Jeong Eun Lee
    Cancer Immunology, Immunotherapy, 2022, 71 : 579 - 588
12345